177 related articles for article (PubMed ID: 11042021)
1. A novel bioassay based on human growth hormone (hGH) receptor mediated cell proliferation: measurement of 20K-hGH and its modified forms.
Ikeda M; Wada M; Fujita Y; Takahashi S; Maekawa K; Honjo M
Growth Horm IGF Res; 2000 Oct; 10(5):248-55. PubMed ID: 11042021
[TBL] [Abstract][Full Text] [Related]
2. 20 kDa human growth hormone (20K hGH) stimulates insulin-like growth factor-I (IGF-I) gene expression at lower concentrations than 22K hGH in hGH receptor-expressing Ba/F3 cells.
Yoshizato H; Tanaka M; Fujikawa T; Higashimoto Y; Shimizu A; Nakashima K
Endocr J; 2000 Mar; 47 Suppl():S37-40. PubMed ID: 10890180
[TBL] [Abstract][Full Text] [Related]
3. The 20-kilodalton (kDa) human growth hormone (hGH) differs from the 22-kDa hGH in the complex formation with cell surface hGH receptor and hGH-binding protein circulating in human plasma.
Wada M; Uchida H; Ikeda M; Tsunekawa B; Naito N; Banba S; Tanaka E; Hashimoto Y; Honjo M
Mol Endocrinol; 1998 Jan; 12(1):146-56. PubMed ID: 9440818
[TBL] [Abstract][Full Text] [Related]
4. The 20-kilodalton (kDa) human growth hormone (hGH) differs from the 22-kDa hGH in the effect on the human prolactin receptor.
Tsunekawa B; Wada M; Ikeda M; Uchida H; Naito N; Honjo M
Endocrinology; 1999 Sep; 140(9):3909-18. PubMed ID: 10465259
[TBL] [Abstract][Full Text] [Related]
5. Specific monoclonal antibodies and ultrasensitive immunoassays for 20K and 22K human growth hormone.
Wu Z; Devany E; Balarini G; Junnila R; Bidlingmaier M; Strasburger CJ
Growth Horm IGF Res; 2010 Jun; 20(3):239-44. PubMed ID: 20304691
[TBL] [Abstract][Full Text] [Related]
6. A novel specific bioassay for serum human growth hormone.
Ishikawa M; Nimura A; Horikawa R; Katsumata N; Arisaka O; Wada M; Honjo M; Tanaka T
J Clin Endocrinol Metab; 2000 Nov; 85(11):4274-9. PubMed ID: 11095467
[TBL] [Abstract][Full Text] [Related]
7. The binding between the stem regions of human growth hormone (GH) receptor compensates for the weaker site 1 binding of 20-kDa human GH (hGH) than that of 22-kDa hGH.
Tsunekawa B; Wada M; Ikeda M; Banba S; Kamachi H; Tanaka E; Honjo M
J Biol Chem; 2000 May; 275(21):15652-6. PubMed ID: 10748003
[TBL] [Abstract][Full Text] [Related]
8. Cellular activities of 20K- and 22K-hGH do not necessarily correlate with their binding affinities for rat GH receptor.
Ikeda M; Matsumoto K; Uchida H; Naito N; Tsunekawa B; Wada M; Honjo M
Horm Res; 2000; 54(3):136-42. PubMed ID: 11357007
[TBL] [Abstract][Full Text] [Related]
9. Analysis of binding properties between 20 kDa human growth hormone (hGH) and hGH receptor (hGHR): the binding affinity for hGHR extracellular domain and mode of receptor dimerization.
Uchida H; Banba S; Wada M; Matsumoto K; Ikeda M; Naito N; Tanaka E; Honjo M
J Mol Endocrinol; 1999 Dec; 23(3):347-53. PubMed ID: 10601980
[TBL] [Abstract][Full Text] [Related]
10. Large-scale preparation and in vitro characterization of biologically active human placental (20 and 22K) and pituitary (20K) growth hormones: placental growth hormones have no lactogenic activity in humans.
Solomon G; Reicher S; Gussakovsky EE; Jomain JB; Gertler A
Growth Horm IGF Res; 2006; 16(5-6):297-307. PubMed ID: 17010651
[TBL] [Abstract][Full Text] [Related]
11. GH induced lipolysis stimulation in 3T3-L1 adipocytes stably expressing hGHR: analysis on signaling pathway and activity of 20K hGH.
Asada N; Takahashi Y; Wada M; Naito N; Uchida H; Ikeda M; Honjo M
Mol Cell Endocrinol; 2000 Apr; 162(1-2):121-9. PubMed ID: 10854705
[TBL] [Abstract][Full Text] [Related]
12. Novel assays based on human growth hormone receptor as alternatives to the rat weight gain bioassay for recombinant human growth hormone.
Roswall EC; Mukku VR; Chen AB; Hoff EH; Chu H; McKay PA; Olson KC; Battersby JE; Gehant RL; Meunier A; Garnick RL
Biologicals; 1996 Mar; 24(1):25-39. PubMed ID: 8733599
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone isoforms.
Baumann GP
Growth Horm IGF Res; 2009 Aug; 19(4):333-40. PubMed ID: 19467614
[TBL] [Abstract][Full Text] [Related]
14. Biological activities of synthesized 20K and 22K hGH in Nb2 bioassay and IM-9 radioreceptor assay.
Ohmae Y; Yano H; Umezawa S; Tanaka T; Hibi I; Miyamoto C; Furuichi Y
Endocrinol Jpn; 1989 Feb; 36(1):9-13. PubMed ID: 2731487
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and purification of a deleted human growth hormone, hGH delta 135-146: sensitivity to plasmin cleavage and in vitro and in vivo bioactivities.
Alam KS; Fujikawa T; Yoshizato H; Tanaka M; Nakashima K
J Biotechnol; 2000 Feb; 78(1):49-59. PubMed ID: 10702910
[TBL] [Abstract][Full Text] [Related]
16. The full agonistic effect of recombinant 20 kDa human growth hormone (hGH) on CHO cells stably transfected with hGH receptor cDNA.
Wada M; Ikeda M; Takahashi Y; Asada N; Chang KT; Takahashi M; Honjo M
Mol Cell Endocrinol; 1997 Oct; 133(2):99-107. PubMed ID: 9406855
[TBL] [Abstract][Full Text] [Related]
17. Exogenous 20K growth hormone (GH) suppresses endogenous 22K GH secretion in normal men.
Hashimoto Y; Kamioka T; Hosaka M; Mabuchi K; Mizuchi A; Shimazaki Y; Tsunoo M; Tanaka T
J Clin Endocrinol Metab; 2000 Feb; 85(2):601-6. PubMed ID: 10690862
[TBL] [Abstract][Full Text] [Related]
18. Serum concentration of 20K human growth hormone (20K hGH) measured by a specific enzyme-linked immunosorbent assay. Study Group of 20K hGH.
Tsushima T; Katoh Y; Miyachi Y; Chihara K; Teramoto A; Irie M; Hashimoto Y
J Clin Endocrinol Metab; 1999 Jan; 84(1):317-22. PubMed ID: 9920101
[TBL] [Abstract][Full Text] [Related]
19. Diabetogenic activity of 20 kDa human growth hormone (20K-hGH) and 22K-hGH in rats.
Takahashi S; Shiga Y; Satozawa N; Hayakawa M
Growth Horm IGF Res; 2001 Apr; 11(2):110-6. PubMed ID: 11472077
[TBL] [Abstract][Full Text] [Related]
20. Construction of a specific and sensitive sandwich enzyme immunoassay for 20 kDa human growth hormone.
Hashimoto Y; Ikeda I; Ikeda M; Takahashi Y; Hosaka M; Uchida H; Kono N; Fukui H; Makino T; Honjo M
J Immunol Methods; 1998 Dec; 221(1-2):77-85. PubMed ID: 9894899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]